نتایج جستجو برای: cyp2c19 polymorphism

تعداد نتایج: 108891  

Journal: :Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences) 2007

Journal: :Drug metabolism and disposition: the biological fate of chemicals 2000
M R Wester J M Lasker E F Johnson J L Raucy

Tolbutamide is a sulfonylurea-type oral hypoglycemic agent whose action is terminated by hydroxylation of the tolylsulfonyl methyl moiety catalyzed by cytochrome P-450 (CYP) enzymes of the human CYP2C subfamily. Although most studies have implicated CYP2C9 as the exclusive catalyst of hepatic tolbutamide hydroxylation in humans, there is evidence that other CYP2C enzymes (e.g., CYP2C19) may als...

2010
ANDREA GAEDIGK

The impact of the CYP2C19*17 allele on the pharmacokinetics of pantoprazole and omeprazole in previously studied children (n 40) was explored. When pantoprazole area under the plasma concentration versus time curve (AUC) was examined as a function of CYP2C19 genotype, a significantly lower AUC was observed for subjects identified as CYP2C19*1/*1 and *1/*17. For pantoprazole, a statistically sig...

Journal: :Rinsho yakuri/Japanese Journal of Clinical Pharmacology and Therapeutics 2009

2016
Kannan Sridharan Rachna Kataria Drishti Tolani Shital Bendkhale Nithya J. Gogtay Urmila M. Thatte

INTRODUCTION CYP2C19 and P2Y12 polymorphisms have been claimed to alter the pharmacodynamic response to clopidogrel. ABCB1 polymorphism has been associated with the efflux of clopidogrel resulting in decreased bioavailability. Due to paucity of data from Indian population, the present study was undertaken to evaluate the association of genetic polymorphisms of CYP2C19, P2Y12, and ABCB1 with inh...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید